The marketed oral semaglutide results in couples of undesirable effects, such as high first-pass effect with very low bioavailability, high inter-subject variation, drug-drug interactions and food effect, GI adverse reactions caused by permeation enhancer
Doctors say the right choice depends on a persons specific symptoms, health history, and whats available right now
The number that stands out to me in the Retatrutide data is not the 24.2% average
For some people, this adjustment can temporarily cause dips in blood sugar, which may leave them feeling weak or tired until their body adapts
Moderation and thoughtful timing can make a meaningful difference
The molecule is the same dual agonist